Management ups guidance after strong Q3
Transferred to National health and Education of Medical Doctors
Wood remains top brokerage
Ryeqq granted marketing authorisation
BUX index reaches another record high in June
Will receive 62% of price as majority owner
In scope of central bank programme
Cariprazine to be sold in more countries
It would be one of the largest issuances in the central bank's programme
Final call on authorisation can be expected in two months
Oral contraceptive to be marketed in Europe
Key dates published
Shares good news about dividend
No new record in sales this quarter
Participation in central bank programme pending BoD approval
Record revenue in Q4 2020, as well
Share price climbs to new all-time high
BUX did well in January 2021 even in international terms
It may be used in the EU only in certain cases